25-11-2022 17:32:09 | Current | ESPI | 10/2022
Legal basis:
Article 17 (1) MAR – confidential information.
Contents of the report:
The Management Board of Median Polska S.A. headquartered in Myslowice _hereinafter “the Company”, “the Issuer”_, with reference to the current report ESPI No. 12/2022 dated August 26, 2022 _”Making a decision on the acquisition of assets and competences to operate in the area of nutraceuticals and dietary supplements production”_ and as a result of the implementation of Resolution No. 27 of the Ordinary General Meeting of the Issuer dated November 4, 2022 on increasing the Company’s share capital by issuing series D ordinary bearer shares in a private placement, with exclusion of preemptive rights of the existing shareholders, dematerialization of ordinary bearer shares of series D and applying for introduction of ordinary bearer shares of series D to trading in the alternative trading system on the NewConnect market, as well as amendments to the Articles of Association of the Company, informs that on November 25, 2022 the Issuer acquired 100% of the shares of the company Hempley sp. z o.o., which is a subsidiary of the Issuer. of shares of Hempley sp. z o.o. with its registered seat in Gdańsk, entered into the Register of Entrepreneurs by the District Court Gdańsk-Północ in Gdańsk, VII Economic Department of the National Court Register, under the number: 0000847433, i.e. 158 shares of Hempley sp. z o.o. with a nominal value of PLN 500 each, with a total nominal value of PLN 79,000. The shares in question were contributed by the existing shareholders of Hempley sp. z o.o. to the Company as a contribution in kind _aport_ in exchange for series D shares of the Company.
The Issuer’s Management Board informs that in connection with the acquisition of 100% of the shares of Hempley sp. z o.o., the company acquired the status of a subsidiary of the Issuer.
Piotr Zawadzki- President of the Management Board
2023. Mycodern S.A.